Organisation paid for research Program year 2025 Source: CMS Open Payments

Baylor Scott and White Research

Neither a doctor nor a teaching hospital

Research payments

$365,413

98 payments

Through program year 2025, Baylor Scott and White Research is reported as receiving $365,413 in research payments, across 98 payments.

By program year

5 rows

Year	Kind	Amount	Payments
2025	Research	$169,804	35
2024	Research	$124,489	42
2023	Research	$11,878	3
2022	Research	$59,230	17
2021	Research	$12	1

Breakdown

Who paid Research payments · program years 2021–2025

Bolton Medical Inc $156,784 41 payments
Pfizer Inc. $91,903 10 payments
Iovance Biotherapeutics, Inc. $44,270 25 payments
Chiesi USA, Inc. $35,283 11 payments
Novartis Pharmaceuticals Corporation $24,269 3 payments
Genentech, Inc. $12,904 8 payments

Studies the money was for Research payments · program years 2021–2025

Tiger Pas $128,476 29 payments
A Phase 3 Openlabel Study of Elranatamab Monotherapy Versus Elotuzumab Pomalidomide Dexamethasone Epd Or Pomalidomide Bortezomib Dexamethasone PVD Or Carfilzomib Dexamethasone KD in Participants With Relapsedrefractory Multiple Myeloma Who Received Prior Anticd38 Directed Therapy $91,903 10 payments
101623 $42,270 24 payments
A Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Iptacopan (Lnp023) in Complement 3 Glomerulopathy $23,770 2 payments
A Study in Preterm Neonates With RDS to Compare Curosurf Administration Through Lisa and Conventional Administration (Lispap) $22,069 7 payments
Branch EFS $17,020 5 payments
Long Term Follow Up Study of Patients With Covid 19 Associated Pneumonia Who Participated in A Desig $12,904 8 payments
A Study in Preterm Neonates With RDS to Compare CUROSURF? Administration Through LISA and Conventional Administration (LISPAP) $11,878 3 payments
RelayPro-A $11,288 7 payments
Iov-Eap-402 $2,000 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.